Parkinson’s Disease: developing highly precise predictive classifiers for early diagnosis and detection - Wesley Research Institute
Wesley Research Institute
Donate
Now

This project will develop new and highly precise predictive classifiers for early diagnosis and detection of Parkinson’s disease based on complex microbial signatures which will inform diagnosis, staging and classification of Parkinson’s disease patients in the clinic.

 

Research Objectives

Status

Current

Recruitment

Open

Study location

Wesley Research Institute, Wesley Research Institute, Queensland University of Technology

Study type

Investigator Initiated

Lead investigator

  • A/Prof John O’Sullivan

Experienced investigator

  • Dr Richard Gordon (QUT)

About this research project

It’s estimated that one in every 1,000 Australians have Parkinson’s disease with approximately 40 people diagnosed everyday. The number of people diagnosed with Parkinson’s disease has increased 17% in the last six years with costs to the community increasing by nearly 50%. It’s the second most common neurodegenerative disease after dementia in Australia.

There are currently no effective biomarkers to accurately diagnose Parkinson’s disease or predict disease progression. Pathological changes in the gut microbiota composition and metabolism occurs early in Parkinson’s disease which drives neuropathology and disease progression. Understanding and characterising the complex changes in gut microbiome composition will provide new opportunities for therapeutic targets and diagnostic biomarkers.

 

Latest News

AI Initiative Targets ‘Beeps and Bongs’ to Revolutionise ICU Care 

A research initiative aiming to leverage Artificial Intelligence’s capabilities to detect early signs of patient deterioration, especially in those undergoing mechanical ventilation, is receiving significant backing from the Wesley Research Institute. At the helm of this innovative project are Dr James Winearls and Professor John Fraser.

Pioneering Research to Advance Pandemic Protection for Youth

A novel research initiative spearheaded by Professor John Fraser and Associate Professor Kirsty Short, is set to lay the groundwork for vaccines and treatments aimed at protecting children and young adults during health crises.

Empowering Cancer Survivors Through Innovative Exercise Therapy 

Dr Janine Porter-Steele and Professor Alexandra (Sandie) McCarthy are leading the FOXTROT project, focusing on delivering telehealth exercise therapy to cancer survivors living with ostomies.  
1 2 3 11
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram